Srinivas Akkaraju - 27 May 2022 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC.

Role
Director
Signature
/s/ Srinivas Akkaraju
Issuer symbol
N/A
Transactions as of
27 May 2022
Net transactions value
+$7,980,000
Form type
4
Filing time
01 Jun 2022, 16:13:24 UTC
Previous filing
31 May 2022
Next filing
02 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KDNY Common Stock Purchase $7,980,000 +570,000 +12% $14.00 5,161,888 27 May 2022 By Samsara BioCapital, L.P. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a purchase from the underwriters in a public offering of the issuer.
F2 Shares held by Samsara BioCapital, L.P. ("Samsara BioCapital"). The reporting person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara BioCapital. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person's pecuniary interest therein.